痴呆症干预措施的成本效益分析:一个范围审查
Tracy Comans1,2, Tiet-Hanh Dao-Tran1, Namal Balasooriya3
1Centre for Health Services Research, Faculty of Health, Medicine & Behavioural Sciences, University of Queensland, Brisbane, Queensland, Australia.
Innovation in aging
|September 22, 2025
概括
痴呆症干预的成本效益分析 (CBA) 越来越常见. 本综述综合了CBA方法,确定了共同的成本和收益,以指导未来对痴呆症护理的评估.
科学领域:
- 卫生经济学 卫生经济学
- 老年学是一门学科.
- 公共卫生政策 公共卫生政策
背景情况:
- 成本效益分析 (CBA) 是评估痴呆症干预措施的关键工具.
- 为了在痴呆症护理中准确进行经济评估,需要标准化的方法.
研究的目的:
- 综合用于痴呆症干预的成本效益分析 (CBA) 的方法.
- 确定在痴呆症护理经济评估中使用的共同的成本和效益组件和估值技术.
主要方法:
- 2010年1月至2023年12月期间发表的同行评审文章的范围审查.
- 进行了系统的搜索,遵守PRISMA扩展范围审查指南.
- 包括的研究对痴呆症干预进行了定量CBA,详细说明了成本和收益.
主要成果:
- 包括15项研究,使用传统的CBA和社会投资回报方法.
- 常见成本包括员工培训和用品;福利往往涉及质量调整寿命年 (QALYs) 和医疗保健利用.
- 数据来源各异,市场/影子定价用于成本和社会价值银行用于收益.
结论:
- 本综合报告提供了CBA方法对痴呆症干预的全面概述.
- 研究结果为研究人员和决策者提供了宝贵的见解,为设计未来痴呆症和相关领域的经济评估提供了宝贵的见解.
相关概念视频
Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
3.1K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.1K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
Community Based Intervention
278
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
278


